A-1 Limited , formerly known as A-1 Acid Limited, has notified BSE Limited of an upcoming Board of Directors meeting pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled to be held on Tuesday, May 12, 2026, at 2:00 P.M. at the company's registered office located at Corporate House No. A-1, Shivalik Business Centre, B/h. Rajpath Club, S. G. Highway, Bodakdev, Ahmedabad - 380059.

Board Meeting Agenda

The board meeting has been convened to address several key items pertaining to the company's financial disclosures for the quarter and year ended March 31, 2026. The following table outlines the primary agenda items:

Trading Window Closure

In line with the company's Code for Prevention of Insider Trading and pursuant to BSE's letter dated April 2, 2019 (Ref. No. LIST/COMP/01/2019), the trading window for dealing in the securities of A-1 Limited has been closed for all designated persons. The closure is effective from April 1, 2026, and will remain in force until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026.

The intimation was signed by Harshadkumar Naranbhai Patel, Chairman & Managing Director (DIN: 00302819), on May 4, 2026, on behalf of A-1 Limited.

A-1 Limited has issued a comprehensive clarification to BSE Limited under Regulation 30 of SEBI (LODR) Regulations, 2015, categorically denying false rumors about acquiring a 20% stake in Yashvi Lifesciences. The company responded to BSE's inquiry regarding misleading information circulated on the Telegram channel 'Chase Alpha-SEBI REG'.

Official BSE Filing Details

The company filed its clarification on April 15, 2026, addressing BSE's email dated April 13, 2026. A-1 Limited described the circulated information as "completely false, baseless and fabricated." The filing was signed by Company Secretary and Compliance Officer Nidhi Chokshi.

Key Clarifications Provided

A-1 Limited made four specific clarifications in its BSE filing. The company confirmed no acquisition of any stake in Yashvi Lifesciences has occurred, nor is any such proposal under Board consideration. Additionally, the company stated it has no affiliation with the Telegram channel 'Chase Alpha' or its operators.

Regulatory Compliance and Legal Action

The company emphasized its commitment to corporate governance and transparency, confirming strict compliance with Regulation 30 requirements. A-1 Limited assured that any material events or unpublished price-sensitive information will be promptly disclosed to exchanges as mandated.

Market Protection Measures

A-1 Limited strongly condemned the dissemination of misleading information aimed at manipulating investor sentiment. The management is evaluating appropriate legal actions against entities responsible for spreading false news. The company filed the formal clarification to protect shareholder interests and dispel market rumors effectively.